Valuation: Hikma Pharmaceuticals PLC

Market Cap 4.42B 3.87B 3.58B 3.29B 6.21B 426B 6.31B 42.8B 16.78B 208B 16.59B 16.23B 718B P/E 2026 *
11.3x
P/E 2027 * 10.1x
Enterprise Value 5.89B 5.16B 4.77B 4.39B 8.28B 568B 8.41B 57.05B 22.36B 278B 22.11B 21.63B 957B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
63.65%
Yield 2026 *
4.02%
Yield 2027 * 4.27%
1 day-1.38%
1 week-2.16%
Current month+1.32%
1 month+3.56%
3 months+11.80%
6 months+0.85%
Current year-0.65%
1 week 1,483
Extreme 1483
1,573
1 month 1,469
Extreme 1469
1,762
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
2,052
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,703
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 2025-11-30
Director of Finance/CFO - 2026-02-25
Chief Tech/Sci/R&D Officer 64 2026-02-25
Director TitleAgeSince
Director/Board Member 69 2005-10-13
Director/Board Member 54 2025-12-14
Chairman 69 2014-05-14
Date Insider Type Main position Quantity % Market Cap.
6/1/26 Fiscal year

Director

72,763 0.0339%
6/1/26 Fiscal year

Director

20,650 0.0096%
6/1/26 Fiscal year

Head of Human Resources

28,631 0.0133%
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-2.16%-22.92%-25.35% 4.42B
-2.31%-1.59%+52.60%+150.76% 1,051B
-1.41%-3.05%+52.04%+48.41% 609B
-0.56%+2.11%+36.99%+78.09% 450B
-0.75%+0.30%+29.77%+21.15% 330B
-1.52%-1.19%+34.46%+35.35% 284B
-1.70%-1.82%+20.99%+15.74% 263B
-0.58%+1.11%-20.18%-40.59% 223B
-0.44%+1.34%+23.46%+56.62% 198B
-0.41%+1.69%+23.40%+67.14% 167B
Average -1.02%+0.34%+23.06%+40.73% 357.95B
Weighted average by Cap. -1.15%+0.02%+37.07%+71.93%

Financials

2026 *2027 *
Net sales 3.46B 3.03B 2.8B 2.58B 4.86B 334B 4.94B 33.51B 13.14B 163B 12.99B 12.71B 562B 3.61B 3.17B 2.93B 2.69B 5.08B 349B 5.16B 35.02B 13.73B 171B 13.57B 13.28B 588B
Net income 405M 355M 328M 302M 569M 39.03B 578M 3.92B 1.54B 19.1B 1.52B 1.49B 65.8B 443M 388M 359M 330M 622M 42.68B 632M 4.29B 1.68B 20.88B 1.66B 1.63B 71.95B
Net Debt 1.47B 1.29B 1.19B 1.1B 2.07B 142B 2.1B 14.25B 5.59B 69.39B 5.52B 5.4B 239B 1.31B 1.15B 1.07B 980M 1.85B 127B 1.88B 12.74B 4.99B 62.03B 4.94B 4.83B 214B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and non-licensed pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Generics. It supplies hospitals across its markets with generic and specialty injectable products, supported by its manufacturing facilities in the United States (US), Europe and Middle East/North Africa (MENA). It supplies branded generic and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. It supplies oral, respiratory and other generic and specialty products to the North American retail market. Its manufacturing facilities in the US supply generic and specialty products to the US and Canada markets across a broad range of therapeutic areas, including respiratory, oncology and pain management.
Employees
9,400
Date Price Change Volume
26-07-20 GBX 1,540.00 -1.35% 640,598
26-07-17 GBX 1,561.00 +0.64% 1,494,149
26-07-16 GBX 1,551.00 +3.75% 904,819
26-07-15 GBX 1,495.00 -0.07% 752,708
26-07-14 GBX 1,496.00 -4.96% 928,305
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.00USD
Average target price
24.88USD
Spread / Average Target
+18.45%

Quarterly revenue - Rate of surprise